Top

Published in:

01-07-2006 | Original Article

Multi-modal approach to prophylaxis of necrotizing enterocolitis: clinical report and review of literature

Authors: G. Schmolzer, B. Urlesberger, Michaela Haim, J. Kutschera, G. Pichler, E. Ritschl, B. Resch, F. Reiterer, W. Müller

Published in: Pediatric Surgery International | Issue 7/2006

Abstract

For the first time a multimodal approach to NEC prophylaxis is reported, consisting of early trophic feeding with human breast milk, and enteral administration of an antibiotic, an antifungal agent, and probiotics. A retrospective analysis of local protocol of NEC prophylaxis is presented. Included were all VLBWI admitted to the NICU, including transfers within the first 28 days of life. These infants were divided into two groups, an “inborn group” (infants admitted within the first 24 h of life) and an “outborn group” (infants admitted after the onset of their second day of life). Prophylaxis of NEC according to protocol was started at the day of admission, and was continued until discharge. Between 1998 and 2004, 405 VLBWI were admitted, including all transfers within the first 28 days of life. A total of 334 (82%) infants were admitted within the first 24 h of life (inborn group), and 71 (18%) were admitted after 24 h of life (outborn group). Five infants developed clinical features of necrotizing enterocolitis. The inborn group showed a NEC incidence of 0.7% (two infants), whereas the outborn group showed a NEC incidence of 4.5% (three infants), respectively. This difference was significant (P=0.049, Fisher’s exact test). A surgical treatment with bowel resection was performed in two infants (both from the outborn group). The present study used a combination of different strategies, all having shown to have some beneficial effect, but not having brought a clinical breakthrough in single administration studies. Combinated were the beneficial effects of human breast milk feeding, oral antiobiotics, oral antifungal agents, and the administration of probiotics. In a homogenous group of preterm infants, using this protocol of multimodal NEC prophylaxis, there was a very low incidence of NEC, when started within the first 24 h of life.

Agarwal R, Sharma N, Chaudhry R, Deorari A, Paul VK, Gewolb IH, Panigrahi P (2006) Effects of oral lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr 36:397–402CrossRef

Austin NC, Darlow B (2004) Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants. Cochrane Database Syst Rev (1):CD003478

Ballance WA, Dahms BB, Shenker N, Kliegman RM (1990) Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 117(1 Pt 2):S6–S13PubMed

Bell EF (2005) Preventing necrotizing enterocolitis: what works and how safe? Pediatrics 115(1):173–174PubMed

Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T (1978) Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187(1):1–7PubMedCrossRef

Berseth CL (2005) Feeding strategies and necrotizing enterocolitis. Curr Opin Pediatr 17(2):170–173PubMedCrossRef

Berseth CL, Bisquera JA, Paje VU (2003) Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 111(3):529–534PubMedCrossRef

British Association for Perinatal Paediatrics and the Public Health Laboratory Service Communicable Disease Surveillance Centre (1983) Surveillance of necrotising enterocolitis, 1981–82. Br Med J 287:824–826

Brown EG, Sweet AY (1978) Preventing necrotizing enterocolitis in neonates. JAMA 240:2452–2454PubMedCrossRef

10.

Bury RG, Tudehope D (2001) Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev (1):CD000405

11.

Caplan MS, Sun XM, Hseuh W, Hageman JR (1990) Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 116(6):960–964PubMedCrossRef

12.

Caplan MS, Lickerman M, Adler L, Dietsch GN, Yu A (1997) The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 42(6):779–783PubMedCrossRef

13.

Cooke L, Steer P, Woodgate P (2003) Indomethacin for asymptomatic patent ductus arteriosus in preterm infants (Review). Cochrane Database Syst Rev (2):CD003745

14.

Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: a prospective double-blind study. Biol Neonate 82(2):103–108PubMedCrossRef

15.

Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, Stepankova R, Payne CM, McCuskey RS (2002) Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 282(1):G156–G164PubMed

16.

Eibl MM, Wolf HM, Furnkranz H, Rosenkranz A (1988) Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA–IgG feeding. N Engl J Med 319(1):1–7PubMedCrossRef

17.

Fast C, Rosegger H (1994) Necrotizing enterocolitis prophylaxis: oral antibiotics and lyophilized enterobacteria vs oral immunoglobulins. Acta Paediatr Suppl 396:86–90PubMedCrossRef

18.

Foster J, Cole M (2004) Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth-weight neonates. Cochrane Database Syst Rev (1):CD001816

19.

Fowlie PW (1996) Prophylactic indomethacin: systematic review and meta-analysis (Review). Arch Dis Child Fetal Neonatal Ed 74(2):F81–F87PubMed

20.

Fowlie PW, Davis PG (2002) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants (Review). Cochrane Database Syst Rev (3):CD000174

21.

Fowlie PW, Davis PG (2003) Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis (Review). Arch Dis Child Fetal Neonatal Ed 88(6):F464–F466PubMedCrossRef

22.

Furukawa M, Lee EL, Johnston JM (1993) Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. Pediatr Res 34(2):237–241PubMedCrossRef

23.

Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW, Rescorla FJ, Scherer LR III (1996) Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 224(3):350–355PubMedCrossRef

24.

Gross SJ (1983) Growth and biochemical response of preterm infants fed human milk or modified infant formula. N Engl J Med 308(5):237–241PubMedCrossRef

25.

Gross SJ, David RJ, Bauman L, Tomarelli RM (1980) Nutritional composition of milk produced by mothers delivering preterm. J Pediatr 96(4):641–644PubMedCrossRef

26.

Grylack LJ, Scanlon JW (1978) Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis. A controlled double-blind trial. Am J Dis Child 132(12):1192–1194PubMed

27.

Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody J, Clark RH (2003) Necrotizing enterocolitis among neonates in the United States. J Perinatol 23(4):278–285PubMedCrossRef

28.

Hammerman C, Bin-Nun A, Kaplan M (2004) Germ warfare: probiotics in defense of the premature gut (Review). Clin Perinatol 31(3):489–500PubMedCrossRef

29.

Henry MC, Moss RL (2004) Current issues in the management of necrotizing enterocolitis (Review). Semin Perinatol 28(3):221–233PubMedCrossRef

30.

Holman RC, Stoll BJ, Clarke MJ, Glass RI (1997) The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 87(12):2026–2031PubMedCrossRef

31.

Horbar JD, Badger GJ, Lewit EM, Rogowski J, Shiono PH (1997) Hospital and patient characteristics associated with variation in 28-day mortality for very low birth weight infants. Pediatrics 99:149–156PubMedCrossRef

32.

Hoyos AB (1999) Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infec Dis 3:197–202CrossRef

33.

Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F (2003) Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 6(1):6–23. Epub 2002 Nov 11 (Review)

34.

Iacopetta BJ, Grieu F, Horisberger M, Sunahara GI (1992) Epidermal growth factor in human and bovine milk. Acta Paediatr 81(4):287–291PubMedCrossRef

35.

Kamitsuka MD, Horton MK, Williams MA (2000) The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1,250 and 2,500 g and less than 35 weeks of gestation. Pediatrics 105(2):379–384PubMedCrossRef

36.

Kliegman RM, Fanaroff AA (1981) Neonatal necrotizing enterocolitis: a nine-year experience. Am J Dis Child 135(7):603–607PubMed

37.

Kosloske AM (1984) Pathogenesis and prevention of necrotizing enterocolitis: a hypothesis based on personal observation and a review of the literature (Review). Pediatrics 74(6):1086–1092PubMed

38.

Ladd AP, Rescorla FJ, West KW, Scherer LR III, Engum SA, Grosfeld JL (1998) Long-term follow-up after bowel resection for necrotizing enterocolitis: factors affecting outcome. J Pediatr Surg 33(7):967–972PubMedCrossRef

39.

Lindemann PC, Foshaugen I, Lindemann R (2004) Characteristics of breast milk and serology of women donating breast milk to a milk bank. Arch Dis Child Fetal Neonatal Ed 89(5):F440–F441PubMedCrossRef

40.

Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, Oh William (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115(1):1–4PubMed

41.

Lucas A, Cole TJ (1990) Breast milk and neonatal necrotising enterocolitis. Lancet 336(8730):1519–1523PubMedCrossRef

42.

Manzoni P, Maestri A, Gomirato G, Takagi H, Watanabe D, Matsui S (2005) Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics

43.

McGuire W, Anthony MY (2001) Formula milk versus preterm human milk for feeding preterm or low birth weight infants (Review). Cochrane Database Syst Rev (3):CD002972

44.

McGuire W, Anthony MY (2003) Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed 88:F11–F14PubMedCrossRef

45.

Ment LR, Oh W, Ehrenkranz RA, Phillip AG, Vohr B, Allan W, Makuch RW, Taylor KJ, Schneider KC, Katz KH et al (1994) Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 124(6):951–955PubMedCrossRef

46.

Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, Duncan CC, Scott DT, Taylor KJ, Katz KH et al (1994) Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 93(4):543–550PubMed

47.

Mercado MC, Brodsky NL, McGuire MK, Hurt H (2004) Extended interval dosing of gentamicin in preterm infants. Am J Perinatol 21(2):73–77PubMedCrossRef

48.

Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376(6538):337–341PubMedCrossRef

49.

Millar M, Wilks M, Costeloe K (2003) Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed 88:F354–F358PubMedCrossRef

50.

Nadler EP, Upperman JS, Ford HR (2001) Controversies in the management of necrotizing enterocolitis. Surg Infect (Larchmt) Summer 2(2):113–119; discussion 119–120 (Review)

51.

Neu J (1996) Necrotizing enterocolitis: the search of an unifying pathogenic theory leading to prevention. Pediatr Clin North Am 43:409–432PubMedCrossRef

52.

Noerr B (2003) Current controversies in the understanding of necrotizing enterocolitis. Part 1 (Review). Adv Neonatal Care 3(3):107–120PubMedCrossRef

53.

Raiha NC, Heinonen K, Rassin DK, Gaull GE (1976) Milk protein quantity and quality in low-birthweight infants: I. Metabolic responses and effects on growth. Pediatrics 57(5):659–684PubMed

54.

Reber KM, Nankervis CA (2004) Necrotizing enterocolitis: preventative strategies (Review). Clin Perinatol 31(1):157–167PubMedCrossRef

55.

Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice (Review). Clin Microbiol Rev 16(4):658–672PubMedCrossRef

56.

Richter D, Bartmann P, Pohlandt F (1998) Prevention of necrotizing enterocolitis in extremely low birth weight infants by IgG feeding? Eur J Pediatr 157(11):924–925PubMedCrossRef

57.

Rothmann D, Udall JN, Pang KY, Kirkham SE, Walker WA (1985) The effect of short-term starvation in the newborn rabbit. Pediatr Res 19:727–731CrossRef

58.

Rowley MP, Dahlenburg GW (1978) Gentamicin in prophylaxis of neonatal necrotising enterocolitis. Lancet 2(8088):532PubMedCrossRef

59.

Rubaltelli FF, Benini F, Sala M (1991) Prevention of necrotizing enterocolitis in neonates at risk by oral administration of monomeric IgG. Dev Pharmacol Ther 17(3–4):138–143PubMed

60.

Sankaran K, Puckett B, Lee DSC, Seshia M, Boulton J, Qiu Z, Lee SK, The Canadian Neonatal Network (2004) Variations in incidence of necrotizing enterocolitis in canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr 39:366–372

61.

Schanler RJ, Lau C, Hurst NM, Smith EO (2005) Randomized trial of donor human milk versus preterm formula as substitutes for mothers’ own milk in the feeding of extremely premature infants. Pediatrics 116(2):400–406PubMedCrossRef

62.

Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA (2004) Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization (Review). J Pediatr Gastroenterol Nutr 38:293–297PubMedCrossRef

63.

Shimura K (1990) Necrotizing enterocolitis? A Japanese survey. NICU 3:5–7

64.

Shin CE, Falcone RA Jr, Stuart L, Erwin CR, Warner BW (2000) Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 35(2):173–176; discussion 177

65.

Sims ME, Yoo Y, You H, Salminen C, Walther FJ (1988) Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol 5(1):33–36PubMedCrossRef

66.

Siu YK, Ng PC, Fung SC, Lee CH, Wong MY, Fok TF, So KW, Cheung KL, Wong W, Cheng AF (1998) Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 79(2):F105–F109PubMedCrossRef

67.

Stein H, Cohen D, Herman AA, Rissik J, Ellis U, Bolton K, Pettifor J, MacDougall L (1986) Pooled pasteurized breast milk and untreated own mother’s milk in the feeding of very low birth weight babies: a randomized controlled trial. J Pediatr Gastroenterol Nutr 5(2):242–247PubMedCrossRef

68.

Stoll B (1994) Epidemiology of necrotizing enterocolitis. Clin Perinatol 21:205–219PubMed

69.

Tyson JE, Lasky RE, Mize CE, Richards CJ, Blair-Smith N, Whyte R, Beer AE (1983) Growth, metabolic response, and development in very-low-birth-weight infants fed banked human milk or enriched formula. I. Neonatal findings. J Pediatr 103(1):95–104PubMedCrossRef

70.

Walsh MC, Kliegman RM (1986) Necrotizing enterocolitis: treatment based on staging criteria (Review). Pediatr Clin North Am 33(1):179–201PubMed

71.

Wight NE (2001) Donor human milk for preterm infants. J Perinatol 21(4):249–254PubMedCrossRef

72.

Wight NE (2003) Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. J Pediatr 143(1):137–138PubMedCrossRef

73.

Wight NE (2005) Donor milk: down but not out. Pediatrics. 116(6):1610; author reply 1610–1611

Title: Multi-modal approach to prophylaxis of necrotizing enterocolitis: clinical report and review of literature
Authors: G. Schmolzer
B. Urlesberger
Michaela Haim
J. Kutschera
G. Pichler
E. Ritschl
B. Resch
F. Reiterer
W. Müller
Publication date: 01-07-2006
Publisher: Springer-Verlag
Published in: Pediatric Surgery International / Issue 7/2006
Print ISSN: 0179-0358
Electronic ISSN: 1437-9813
DOI: https://doi.org/10.1007/s00383-006-1709-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multi-modal approach to prophylaxis of necrotizing enterocolitis: clinical report and review of literature

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2006

In vivo bladder regeneration using small intestinal submucosa: experimental study

Pure esophageal atresia with no gap and associated intra-abdominal calcification

Impact of collagen subtype proportions in peritoneal tissues on inguinal hernia formation in adults and infants

Splenoptosis complicated by a large splenic cyst: case report and discussion of combined management

Mesenchymal hamartoma of the liver: is biopsy always necessary?

Pleural effusion requiring drainage in congenital diaphragmatic hernia: incidence, aetiology and treatment